Former Pharmaceutical Company Executive Picked to Run HHS

Former Pharmaceutical Company Executive Picked to Run HHS

Former Pharmaceutical Company Executive Picked to Run HHS

Azar has close political ties with Republican lawmakers and observers believe that during his time with Lilly (and Indiana-based company), he developed a relationship with Vice President Pence.

But Sanders was skeptical that Azar is the right choice for the top HHS post, especially as the United States aims to lower skyrocketing prescription drug prices.

The Department of Health and Human Services is a cabinet-level department of the USA federal government with a mission of protecting the health of Americans.

President Trump has selected Alex Azar to replace Tom Price as secretary of HHS. "He also had complete responsibility for the administrative rulemaking process at HHS which will be used extensively in changing the existing law", said Leavitt. "I will vigorously oppose this nomination".

Azar's nomination must be approved by the US Senate, which is controlled by Trump's fellow Republicans. He has the experience and expertise to combine the best from the private sector with the best of our public programs to make healthcare work for every American.

Dr. Azar's father immigrated to the US from Lebanon about 100 years ago, now his grandson is serving in the nation's cabinet. "This is someone who understands the complex system we've built-and the warped channel incentives baked into the system".

The AHA and the Healthcare Information and Management Systems Society welcomed Azar's nomination.

Chip Kahn, president and CEO of the Federation of American Hospitals, the national advocacy organization for investor-owned hospitals, made similar comments. Azar calls Starr a mentor.

At Eli Lilly, he served as senior vice president for the firm's global communications and government affairs unit.

When he worked with HLC, Grealy said that during deliberations, he was a strong and influential voice for health system transformation to achieve greater value as defined by affordability and consistent clinical quality without disparities.

"I'm very proud of him", Dr. Azar said, according to Delmarva Now.

Democratic Senator Patty Murray, who has been working on bipartisan healthcare legislation, tweeted, "Given Alex Azar's professional background, there are concerns on whether he can fairly execute any significant effort to lower drug prices for patients & families". Over the course of the past year, HHS has dramatically cut outreach and advertising funding for open enrollment under Obamacare, and President Trump ended cost-sharing subsidies to help fund insurance for low-income individuals.